We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$5.27B
AUM Growth
+$317M
Cap. Flow
-$90.4M
Cap. Flow %
-1.72%
Top 10 Hldgs %
18.18%
Holding
150
New
11
Increased
79
Reduced
42
Closed
18

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$45.2M
2
CST
CST Brands, Inc.
CST
+$28.8M
3
ZTS icon
Zoetis
ZTS
+$26.9M
4
ADT
ADT Corp
ADT
+$26.6M
5
BJRI icon
BJ's Restaurants
BJRI
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.62%
2 Industrials 16.17%
3 Financials 14.3%
4 Consumer Discretionary 10.25%
5 Technology 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFSI
101
DELISTED
AmTrust Financial Services, Inc.
AFSI
$19M 0.36%
974,410
-848,884
-47% -$15.8M
PNR icon
102
Pentair
PNR
$10.8B
$18.7M 0.36%
429,815
+24,703
+6% +$1.03M
TROW icon
103
T. Rowe Price
TROW
$25.5B
$18.5M 0.35%
256,880
+21,635
+9% +$1.6M
SIAL
104
DELISTED
SIGMA - ALDRICH CORP
SIAL
$17.7M 0.34%
207,825
+5,365
+3% +$451K
ILMN icon
105
Illumina
ILMN
$29.5B
$17.7M 0.34%
225,147
-121,685
-35% -$9.31M
INDB icon
106
Independent Bank
INDB
$4.04B
$17.6M 0.33%
493,540
-500
-0.1% -$18.2K
QGENF
107
DELISTED
QIAGEN NV
QGENF
$17.5M 0.33%
819,085
+41,900
+5% +$897K
GMED icon
108
Globus Medical
GMED
$11.1B
$17.5M 0.33%
+1,003,070
New +$17.4M
ACH
109
Accendra Health
ACH
$254M
$17.1M 0.32%
493,030
-610
-0.1% -$21.3K
K
110
DELISTED
Kellanova
K
$17M 0.32%
308,227
-55,960
-15% -$3.34M
KEG
111
DELISTED
KEY ENERGY SERVICES INC
KEG
$16.5M 0.31%
2,264,660
-144,205
-6% -$1.05M
TUP
112
DELISTED
Tupperware Brands Corporation
TUP
$16.2M 0.31%
187,365
-19,320
-9% -$1.61M
MG icon
113
Mistras Group
MG
$477M
$15.7M 0.3%
922,430
-49,245
-5% -$863K
SWI
114
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
$14.8M 0.28%
422,855
+148,035
+54% +$5.79M
SXI icon
115
Standex International
SXI
$3.33B
$14.2M 0.27%
238,510
+135,810
+132% +$7.83M
MJN
116
DELISTED
Mead Johnson Nutrition Company
MJN
$14.1M 0.27%
189,955
+11,435
+6% +$857K
FTK icon
117
Flotek Industries
FTK
$789M
$14M 0.27%
101,357
-166
-0.2% -$20.1K
FLTX
118
DELISTED
Fleetmatics Group PLC
FLTX
$13.5M 0.26%
358,270
+288,470
+413% +$11.6M
KOG
119
DELISTED
KODIAK OIL & GAS CORP
KOG
$11.6M 0.22%
962,505
+2,515
+0.3% +$25.2K
PLL
120
DELISTED
PALL CORP
PLL
$10.6M 0.2%
137,790
+25,485
+23% +$1.83M
AME icon
121
Ametek
AME
$53.9B
$10M 0.19%
217,200
+10,775
+5% +$485K
SIVB
122
DELISTED
SVB Financial Group
SIVB
$9.79M 0.19%
+113,350
New +$9.8M
CHD icon
123
Church & Dwight Co
CHD
$23.7B
$9.36M 0.18%
311,870
+13,600
+5% +$419K
XPRO icon
124
Expro Ltd
XPRO
$1.66B
$9.27M 0.18%
+51,617
New +$8.69M
ARCO icon
125
Arcos Dorados Holdings
ARCO
$1.74B
$8.97M 0.17%
777,898
-40,445
-5% -$463K

Similar funds

Champlain Investment Partners's Q3 2013 Portfolio in Review

As of Q3 2013, Champlain Investment Partners held 150 positions worth $5.27B, up 6.4% from $4.95B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Champlain Investment Partners's Q3 2013 filing shows 11 new, 79 increased, 42 reduced and 18 closed positions. Its largest new stake was Haemonetics: 1,078,265 shares worth $43M. The largest sale was LUFKIN IND INC, an estimated $94M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

  • Champlain Investment Partners's largest Q3 2013 buy was Haemonetics: 1,078,265 shares worth $43M.
  • Champlain Investment Partners added most to CST Brands, Inc. in Q3 2013, an estimated $28.8M increase.
  • Champlain Investment Partners's biggest Q3 2013 reduction was Protolabs, cutting an estimated $36.4M.
  • Champlain Investment Partners fully exited LUFKIN IND INC in Q3 2013, selling an estimated $94M.
  • Champlain Investment Partners's ten largest holdings make up 18% of its $5.27B portfolio in Q3 2013.
  • Champlain Investment Partners opened 11 new positions and closed 18 in Q3 2013.
  • Champlain Investment Partners's portfolio value rose 6.4% quarter-over-quarter to $5.27B.

Based on Champlain Investment Partners's 13F filing for Q3 2013, filed 12 Nov 2013.